BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

246 related articles for article (PubMed ID: 22566014)

  • 1. Prognostic importance of the extent of ulceration in patients with clinically localized cutaneous melanoma.
    In 't Hout FE; Haydu LE; Murali R; Bonenkamp JJ; Thompson JF; Scolyer RA
    Ann Surg; 2012 Jun; 255(6):1165-70. PubMed ID: 22566014
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Is ulceration in cutaneous melanoma just a prognostic and predictive factor or is ulcerated melanoma a distinct biologic entity?
    Eggermont AM; Spatz A; Lazar V; Robert C
    Curr Opin Oncol; 2012 Mar; 24(2):137-40. PubMed ID: 22234255
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prognostic significance of extent of ulceration in primary cutaneous melanoma.
    Grande Sarpa H; Reinke K; Shaikh L; Leong SP; Miller JR; Sagebiel RW; Kashani-Sabet M
    Am J Surg Pathol; 2006 Nov; 30(11):1396-400. PubMed ID: 17063079
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prognostic stratification of ulcerated melanoma: not only the extent matters.
    Bønnelykke-Behrndtz ML; Schmidt H; Christensen IJ; Damsgaard TE; Møller HJ; Bastholt L; Nørgaard PH; Steiniche T
    Am J Clin Pathol; 2014 Dec; 142(6):845-56. PubMed ID: 25389339
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Tumor mitotic rate is a more powerful prognostic indicator than ulceration in patients with primary cutaneous melanoma: an analysis of 3661 patients from a single center.
    Azzola MF; Shaw HM; Thompson JF; Soong SJ; Scolyer RA; Watson GF; Colman MH; Zhang Y
    Cancer; 2003 Mar; 97(6):1488-98. PubMed ID: 12627514
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prognostic groups of patients with stage I melanoma.
    Kuehnl-Petzoldt C; Wiebelt H; Berger H
    Arch Dermatol; 1983 Oct; 119(10):816-9. PubMed ID: 6614950
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prognostic Significance of Incipient Ulceration in Primary Cutaneous Melanoma.
    Paver EC; Ahmed T; Burke H; Saw RPM; Stretch JR; Spillane AJ; Shannon KF; Vergara IA; Elder DE; Lo SN; Thompson JF; Scolyer RA
    JAMA Dermatol; 2023 Dec; 159(12):1359-1367. PubMed ID: 37910123
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Independent prognostic importance of vascular invasion in nodular melanomas.
    Straume O; Akslen LA
    Cancer; 1996 Sep; 78(6):1211-9. PubMed ID: 8826942
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prognostic factors in patients with thick cutaneous melanoma (> 4 mm).
    Zettersten E; Sagebiel RW; Miller JR; Tallapureddy S; Leong SP; Kashani-Sabet M
    Cancer; 2002 Feb; 94(4):1049-56. PubMed ID: 11920475
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Thick cutaneous malignant melanoma: a reappraisal of prognostic factors.
    Massi D; Borgognoni L; Franchi A; Martini L; Reali UM; Santucci M
    Melanoma Res; 2000 Apr; 10(2):153-64. PubMed ID: 10803716
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A retrospective observational study of primary cutaneous malignant melanoma patients treated with excision only compared with excision biopsy followed by wider local excision.
    McKenna DB; Lee RJ; Prescott RJ; Doherty VR
    Br J Dermatol; 2004 Mar; 150(3):523-30. PubMed ID: 15030337
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Breslow thickness and clark level in melanoma: support for including level in pathology reports and in American Joint Committee on Cancer Staging.
    Marghoob AA; Koenig K; Bittencourt FV; Kopf AW; Bart RS
    Cancer; 2000 Feb; 88(3):589-95. PubMed ID: 10649252
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Sentinel lymph node micrometastasis and other histologic factors that predict outcome in patients with thicker melanomas.
    Cherpelis BS; Haddad F; Messina J; Cantor AB; Fitzmorris K; Reintgen DS; Fenske NA; Glass LF
    J Am Acad Dermatol; 2001 May; 44(5):762-6. PubMed ID: 11312421
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The prognostic significance of ulceration of cutaneous melanoma.
    Balch CM; Wilkerson JA; Murad TM; Soong SJ; Ingalls AL; Maddox WA
    Cancer; 1980 Jun; 45(12):3012-7. PubMed ID: 7388745
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Impact of ulceration in stages I to III cutaneous melanoma as staged by the American Joint Committee on Cancer Staging System: an analysis of the German Central Malignant Melanoma Registry.
    Eigentler TK; Buettner PG; Leiter U; Garbe C;
    J Clin Oncol; 2004 Nov; 22(21):4376-83. PubMed ID: 15514379
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Lymphatic invasion identified by monoclonal antibody D2-40, younger age, and ulceration: predictors of sentinel lymph node involvement in primary cutaneous melanoma.
    Niakosari F; Kahn HJ; McCready D; Ghazarian D; Rotstein LE; Marks A; Kiss A; From L
    Arch Dermatol; 2008 Apr; 144(4):462-7. PubMed ID: 18427039
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cancer-testis antigen expression in primary cutaneous melanoma has independent prognostic value comparable to that of Breslow thickness, ulceration and mitotic rate.
    Svobodová S; Browning J; MacGregor D; Pollara G; Scolyer RA; Murali R; Thompson JF; Deb S; Azad A; Davis ID; Cebon JS
    Eur J Cancer; 2011 Feb; 47(3):460-9. PubMed ID: 21115342
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The importance of mitotic rate as a prognostic factor for localized cutaneous melanoma.
    Barnhill RL; Katzen J; Spatz A; Fine J; Berwick M
    J Cutan Pathol; 2005 Apr; 32(4):268-73. PubMed ID: 15769275
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Gene expression profiling of primary cutaneous melanoma and clinical outcome.
    Winnepenninckx V; Lazar V; Michiels S; Dessen P; Stas M; Alonso SR; Avril MF; Ortiz Romero PL; Robert T; Balacescu O; Eggermont AM; Lenoir G; Sarasin A; Tursz T; van den Oord JJ; Spatz A;
    J Natl Cancer Inst; 2006 Apr; 98(7):472-82. PubMed ID: 16595783
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prognostic subclassifications of T1 cutaneous melanomas based on ulceration, tumour thickness and Clark's level of invasion: results of a population-based study from the Swedish Melanoma Register.
    Lyth J; Hansson J; Ingvar C; Månsson-Brahme E; Naredi P; Stierner U; Wagenius G; Lindholm C;
    Br J Dermatol; 2013 Apr; 168(4):779-86. PubMed ID: 23066913
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.